Prevention Of 2019-nCoV Infection Research Articles

Consideration of the Management of Pediatric Fever Clinics During the Novel Coronavirus Pneumonia Outbreak.

Since the outbreak of 2019 novel coronavirus (2019-nCoV) infection in Wuhan City, China, pediatric cases have gradually increased. It is very important to prevent cross-infection in pediatric fever clinics, to identify children with fever in pediatric fever clinics, and to strengthen the management of pediatric fever clinics. According to prevention and control programs, we propose the guidance on the management of pediatric fever clinics during the nCoV pneumonia epidemic period, which outlines in detail how to optimize processes, prevent cross-infection, provide health protection, and prevent disinfection of medical staff. The present consideration statement summarizes current strategies on the pre-diagnosis, triage, diagnosis, treatment, and prevention of 2019-nCoV infection, which provides practical suggestions on strengthening the management of pediatric fever clinics during the nCoV pneumonia epidemic period.

Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection：friend or foe？

2019 novel coronavirus(2019-nCoV) epidemic broke out in Wuhan, Hubei In December 2019. Angiotension converting enzyme 2(ACE2) has been identified as a receptor of 2019-nCoV, which combines with ACE2 by acanthoid glycoprotein in host respiratory epithelial cells. On the other hand, ACE2 has a positive therapeutic effect on a variety of atherosclerotic cardiovascular diseases (ASCVD) and acute lung injury including SARS. Therefore, whether ACE2 is an enemy or a friend of human beings in the context of 2019-nCoV epidemic has become a controversial topic. Based on the related researches of ACE2, this paper analyzes the problem deeply and puts forward the research prospect, hoping to be helpful for the recognition and prevention of 2019-nCoV infection. Key words: SARS-CoV-2; ACE2; Renin-angiotension system

Guidance on strengthening the management processes of children′s fever in outpatient department during the novel coronavirus pneumonia epidemic period (First Edition)

Novel Coronavirus Pneumonia (NCP) is a class B infectious disease, which is prevented and controlled according to class A infectious diseases. Recently, children′s NCP cases have gradually increased, and children′s fever outpatient department has become the first strategic pass to stop the epidemic. Strengthening the management of the fever diagnosis process is very important for early detection of suspected children, early isolation, early treatment and prevention of cross-infection. This article proposes prevention and control strategies for fever diagnosis, optimizes processes, prevents cross-infection, health protection and disinfection of medical staff, based on the relevant diagnosis, treatment, prevention and control programs of the National Health and Health Commission and on the diagnosis and treatment experience of experts in various provinces and cities. The present guidance summarizes current strategies on pre-diagnosis; triage, diagnosis, treatment, and prevention of 2019-nCoV infection in common fever, suspected and confirmed children, which provide practical suggestions on strengthening the management processes of children′s fever in outpatient department during the novel coronavirus pneumonia epidemic period. Key words: Novel Coronavirus; Novel Coronavirus Pneumonia; Child; Fever outpatient; Process; Management